Program Description: 
This is a monthly lecture series, intended to provide updates regarding cancer research, treatment and supportive care to faculty and staff in the Hem-Onc division, and any other interested parties. Lectures are provided by internal or external speakers, who are experts in their topic area.  Examples of talks given include updates in various cancers like lung cancer and melanoma, as well as overview/update about fertility issues related to cancer treatment.
 
Key words: Cancer Treatment Updates
Target audience: 
  • Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Nurses
Learning objectives: 
Participants who engage in this educational intervention will be able to:
  • Identify the differences between first line treatment options in (Renal Cell Carcinoma) RCC
  • Review the evolution of first line treatment options in RCC
  • Dissect underlying biology driving therapeutic advancements in RCC
Faculty & credentials: 
Activity Director(s):
John Charlson, MD
Associate Professor
Department of Medicine
Division of Hematology and Oncology
The Medical College of Wisconsin
 
Planning Committee Member(s):
Kristine Broge-Reynen, APNP
APP Lead
Department of Medicine
Hematology and Oncology
Medical College of Wisconsin
Speaker:
Rana McKay, MD
Oncologist, Cancer Therapy Advisor
UC San Diego Health
 
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all persons in control of content must disclose any relevant financial relationships. It is the policy of the Medical College of Wisconsin to identify, mitigate and disclose the absence or presence of all relevant financial relationships with ineligible companies held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education. The following in control of content had no relevant financial relationships to disclose.
  • Kristine Broge-Reynen

The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.

Name

Company

Role

John Charlson

Ipsen

Deciphera

Adaptimmune

Advisory Committee

Consultant/Speaking or Teaching

Consultant

 

Name
Company
Role
Rana McKay, MD
Ambrx, Arcus, AstraZeneca, Aveo, Bayer, Bristol-Myers Squibb, Calithera, Caris, Dendreon, Exelixis, Johnson & Johnson, Lilly
Consultant

Contact

Name: 
Dan Bullock
Phone number: 
+1 (414) 805-4617
Email: 
[email protected]
Accreditation Statement
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians
 
Designation of Credit Statement
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
 
Hours of Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Session date: 
05/08/2025 - 8:00am to 9:00am CDT
Location: 
Hybrid
Milwaukee, WI 53226
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
Please login or register to take this course.